BAM
INSM icon

Belpointe Asset Management’s Insmed INSM Stock Holding History

Belpointe Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,042
Closed -$17.8K – 1915
2023
Q1 		$17.8K Hold
1,042
– – ﹤0.01% 2373
2022
Q4 		$20.8K Buy
+1,042
New +$20.1K ﹤0.01% 2156

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Belpointe Asset Management's INSM Position: Q2 2023 in Review

Belpointe Asset Management sold out of Insmed (INSM) in Q2 2023, closing a stake of 1,042 shares — an estimated $17.8K sold.

Belpointe Asset Management first reported a position in INSM in Q4 2022 and held it in 2 quarters. The position peaked at $20.8K in Q4 2022. 223 funds tracked by Wall St. Rank hold INSM as of Q2 2023.

  • Belpointe Asset Management reported no remaining Insmed position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 1,042 Insmed shares in Q2 2023, an estimated $17.8K.
  • Belpointe Asset Management first reported a position in Insmed in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Insmed position peaked at $20.8K in Q4 2022.
  • 223 funds tracked by Wall St. Rank held Insmed as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.